“…In the in vitro experimental setting, human eosinophils undergo cytolysis/ETosis by various stimuli, such as calcium ionophore, phorbol 12-myristate 13-acetate, IL-5/granulocyte macrophage colony-stimulating factor with platelet-activating factor, immobilized or aggregated Igs, autoantibodies, and fungi [ 57 , 60 , 61 , 62 , 63 , 64 ]. Eosinophil ETosis (EETosis) has been implicated in a wide range of eosinophilic diseases, such as asthma [ 65 , 66 ], allergic bronchopulmonary aspergillosis [ 67 , 68 ], eosinophilic otitis [ 61 , 69 ], eosinophilic chronic rhinosinusitis (chronic rhinosinusitis with nasal polyps) [ 61 ], hypereosinophilic syndrome [ 36 , 57 , 70 ], Wells syndrome (eosinophilic cellulitis) [ 71 ], eosinophilic granulomatosis with polyangiitis ([EGPA] Churg–Strauss syndrome) [ 72 , 73 ], eosinophilic pneumonia [ 74 , 75 , 76 ], ulcerative colitis [ 59 ], and chronic obstructive pulmonary diseases [ 77 ].…”